Expertise in
5
conditions

Ik-chan U. Song

Daejeon, KR 
Expertise in
5
conditions
Daejeon, KR 

Overview

Ik-chan Song practices practicing medicine in Daejeon, Republic of Korea.

Song is highly rated in 5 conditions, according to our data. Their clinical expertise encompasses Myeloproliferative Neoplasms (MPN), Essential Thrombocythemia, Pernicious Anemia, Polycythemia Vera, and Bone Marrow Transplant.

They are actively involved in clinical research, co-authoring 86 peer reviewed articles and participating in 2 clinical trials.

Locations

Daejeon, Republic of Korea
Other Locations
Seoul, Republic of Korea
Jungnam, Republic of Korea
Incheon St. Mary's Hospital, Incheon, Republic of Korea

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomized, Double-blind Phase 3 Study of Vadastuximab Talirine (SGN-CD33A) Versus Placebo in Combination With Azacitidine or Decitabine in the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)
A Randomized, Double-blind Phase 3 Study of Vadastuximab Talirine (SGN-CD33A) Versus Placebo in Combination With Azacitidine or Decitabine in the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)
Enrollment Status: Terminated
Publish Date: December 12, 2018
Intervention Type: Drug
Study Phase: Phase 3
Phase 2 Study Evaluating the Efficacy of Rituximab Plus Modified VPDL for Newly Diagnosed CD20-Positive Adult Acute Lymphoblastic Leukemia
Phase 2 Study Evaluating the Efficacy of Rituximab Plus Modified VPDL for Newly Diagnosed CD20-Positive Adult Acute Lymphoblastic Leukemia
Enrollment Status: Unknown
Publish Date: July 24, 2018
Intervention Type: Drug
Study Drugs: Rituximab, Modified VPDL
Study Phase: Phase 2
View 1 Less Clinical Trial

86 Total Publications

Recent advances in the treatment of FLT3-mutated acute myeloid leukemia.
Recent advances in the treatment of FLT3-mutated acute myeloid leukemia.
Journal: Blood research
Published: June 07, 2026

Frequently Asked Questions about Ik-chan U. Song

Is Ik-chan U. Song a top-rated expert for Myeloproliferative Neoplasms (MPN)?

MediFind is an objective health platform that identifies experts based on real-world data. Ik-chan U. Song is classified as an Distinguished expert for Myeloproliferative Neoplasms (MPN), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Ik-chan U. Song participate in research or clinical trials?

Yes. Ik-chan U. Song has published 86 articles and abstracts on conditions like Myeloproliferative Neoplasms (MPN). You can view a list of Ik-chan U. Song's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Song's expertise for a condition
ConditionClose
    View All 24 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile